Claim · model-written summary
Difenoconazole gave disease control of 36.74%, following Azoxystrobin.
- Taxon
- Onion
Allium cepat0 - Treatment
- Difenoconazole 25EC @ 0.6 ml l-1e4
- Outcome
- disease controle4
- Direction
- followed bye4
- Value
- 36.74%e4
Not reportedMaterialGeneCompoundOrgan / stageInteractorInteractor roleSecond interactorSecond interactor roleComparatorSettingQualifier
Organisms pictured · Representative pictures of the matched species, not figures from the paper.
Verbatim
t0“against Purple Blotch in Onion (Allium cepa L.)”
e4“Maximum disease control was recorded in Tebuconazol 25 EC @ 1 ml l-1 with PDC of 56.12% which was followed by Azoxystrobin 23SC @ 1ml l-1 with 52.04%, Difenoconazole 25EC @ 0.6 ml l-1 with 36.74%”
Title
Niranjan Mandi; Bhabani Shankar Nayak; Bibhuti Bhusan Sahoo; et al. International Journal of Current Microbiology and Applied Sciences 2020. doi:10.20546/ijcmas.2020.904.235
Other claims from this paper (13)
- Observation Purple blotch PDI in onion varied from 28.67% to 65.33% across treatments.
- Intervention effect Seed treatment with Vitavax plus foliar Tebuconazol was the most effective in reducing PDI, to 28.67%.
- Intervention effect Azoxystrobin 23 SC reduced PDI to 31.33%, at par with the best combined treatment.
- Intervention effect Difenoconazole reduced PDI to 41.33% compared with control.
- Intervention effect Mancozeb reduced PDI to 43.33% compared with control.
- Intervention effect Tebuconazol gave the maximum disease control, 56.12%.
- Intervention effect Azoxystrobin gave disease control of 52.04%, following Tebuconazol.
- Intervention effect Tebuconazol gave the maximum bulb yield, 145.8 q ha-1.
- Intervention effect Azoxystrobin gave bulb yield of 143.3 q ha-1, statistically at par with Tebuconazol.
- Observation Bulb yield in the control plot was 76.1 q ha-1, the minimum recorded.
- Intervention effect Tebuconazol increased bulb yield by 91.59% over the control.
- Intervention effect Tebuconazol gave the maximum B:C ratio, 3.22.
- Intervention effect Azoxystrobin gave a B:C ratio of 3.14, following Tebuconazol.